DM2

Toxic RNA Research Update

Researchers from Dr. Matthew Disney's lab at the Scripps Research Institute of Florida recently published an article describing a new chemical they designed to inhibit the unhealthy repeat-containing RNA molecule seen in DM2.

Promising Small Molecule Study for DM2

Researchers at the University of Illinois recently re-engineered small molecules to disrupt toxic RNA repeats involved in DM2.

DM2 Patients and Statins

Researchers identify the gene believed to be responsible for adverse statin drug side effects in DM2 patients.  

Interesting Findings Reported in Recent DM Research Studies on Sleep Disturbances

Interesting Findings Reported in Recent DM Research Studies on Sleep Disturbances

Interesting Findings Reported in Recent DM Research Studies on Facial Recognition

A recently published study from Sweden reported impaired facial recognition in people with DM1 and indicated that there are brain differences that affect how faces are perceived and stored by people with DM1.

Genetic Testing for Myotonic Dystrophy

Myotonic community members often contact the Foundation with questions about genetic testing. We spoke with Carly Siskind of Stanford's Neuromuscular Team about the pros and cons of testing.

Structure of the Myotonic Dystrophy Type 2 RNA

Researchers at important academic labs around the US have recently published exciting new information about advances in DM research.

Myotonic Grant Recipient Develops Tool for Measuring the Impact of Childhood DM on Quality of Life

To support our commitment to DM research, Myotonic awards fellowship grants to postdoctoral researchers as part of our annual Fund-A-Fellow (FAF) program. We recently caught up with one of our current grant recipients, Dr. Nicholas Johnson, Assistant Professor of Neurology at the University of Utah.

Diagnostic Odyssey of Patients with Myotonic Dystrophy, Journal of Neurology, 2013

Researchers from the University of Rochester recently summarized the “diagnostic odyssey” experienced by a group of 814 individuals with myotonic dystrophy.

A New Study Provides Hope for DM Treatments

Maurice Swanson, Ph.D., Professor of Molecular Genetics and Microbiology at University of Florida, Gainesville, and a team of researchers have found that the muscleblind-like 2 (MBNL2) protein in the central nervous system (CNS) may be responsible for the neurological impacts of myotonic dystrophy

© Myotonic Dystrophy Foundation. All rights reserved.